发展转移性皮肤克罗恩病诊断标准的德尔菲小组:共识声明。

IF 11.5 1区 医学 Q1 DERMATOLOGY
Joseph Ebriani, Karla Santiago-Soltero, Ellen E Anshelevich, Rahul S Dalal, Bridget Shields, Alexandra Charrow, Manasi Agrawal, Afsaneh Alavi, Susan Burgin, Ahuva Cices, Alexandra J Coromilas, Edward W Cowen, Noah Goldfarb, Jennifer L Hsiao, Jean S McGee, Alex G Ortega-Loayza, Martina Porter, Misha Rosenbach, Katharina S Shaw, Karolyn A Wanat, Alice J Watson, Serre-Yu Wong
{"title":"发展转移性皮肤克罗恩病诊断标准的德尔菲小组:共识声明。","authors":"Joseph Ebriani, Karla Santiago-Soltero, Ellen E Anshelevich, Rahul S Dalal, Bridget Shields, Alexandra Charrow, Manasi Agrawal, Afsaneh Alavi, Susan Burgin, Ahuva Cices, Alexandra J Coromilas, Edward W Cowen, Noah Goldfarb, Jennifer L Hsiao, Jean S McGee, Alex G Ortega-Loayza, Martina Porter, Misha Rosenbach, Katharina S Shaw, Karolyn A Wanat, Alice J Watson, Serre-Yu Wong","doi":"10.1001/jamadermatol.2025.1115","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Metastatic cutaneous Crohn disease (MCD) is a rare condition for which there are currently no published diagnostic criteria. Formal MCD diagnostic criteria will expand clinical care and research by enabling future diagnostic code validation, crystallizing a more uniform disease entity for the purposes of translational research, and allowing the development of more formalized outcome measures aimed at treatment response.</p><p><strong>Objective: </strong>To define a set of criteria for the diagnosis of MCD.</p><p><strong>Evidence review: </strong>In this consensus statement, a panel of experts on MCD and related conditions was assembled. Their opinions were gathered regarding the clinical and histologic findings that are sufficient, necessary, and highly suggestive of MCD through serial survey. Subsequent surveys were continued until consensus was achieved. Sufficient was defined as a feature that, if noted, would enable diagnosis of MCD without any other signs, symptoms, or testing. Necessary was defined as a feature that must be present to establish a diagnosis of MCD. Highly suggestive referred to any other features that were indicative of MCD but did not qualify as sufficient or necessary to diagnose MCD.</p><p><strong>Findings: </strong>Of 24 experts invited, 19 agreed to participate, with a 79% to 100% response rate across 5 rounds conducted. Five patients were also invited to participate, but none opted to participate, citing lack of clinical expertise and time concerns. The experts were all from the US; 5 (26%) have practiced medicine for 0 to 5 years, 5 (26%) practiced for 6 to 10 years, 6 (32%) practiced for 11 to 15 years, and 3 (16%) practiced for more than 20 years. A total of 18 experts (95%) worked in an academic practice setting. There was consensus agreement that MCD could present as oral disease, genital disease, or, rarely, in another location. Consensus was achieved on 2 major and 5 minor criteria for genital/other subtypes of MCD and 5 minor criteria for oral MCD. There was consensus that, while there are some pathological findings that are highly suggestive of MCD, histologic criteria are not necessary for diagnosis.</p><p><strong>Conclusions and relevance: </strong>A panel of experts reached consensus on the diagnostic criteria for MCD described in this study. These criteria include major and minor clinical criteria, along with histopathological criteria for the diagnosis of genital and oral MCD. This consensus is a crucial step in the diagnosis of and future treatment development for MCD, a rare and clinically understudied condition.</p>","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":""},"PeriodicalIF":11.5000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease: A Consensus Statement.\",\"authors\":\"Joseph Ebriani, Karla Santiago-Soltero, Ellen E Anshelevich, Rahul S Dalal, Bridget Shields, Alexandra Charrow, Manasi Agrawal, Afsaneh Alavi, Susan Burgin, Ahuva Cices, Alexandra J Coromilas, Edward W Cowen, Noah Goldfarb, Jennifer L Hsiao, Jean S McGee, Alex G Ortega-Loayza, Martina Porter, Misha Rosenbach, Katharina S Shaw, Karolyn A Wanat, Alice J Watson, Serre-Yu Wong\",\"doi\":\"10.1001/jamadermatol.2025.1115\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Importance: </strong>Metastatic cutaneous Crohn disease (MCD) is a rare condition for which there are currently no published diagnostic criteria. Formal MCD diagnostic criteria will expand clinical care and research by enabling future diagnostic code validation, crystallizing a more uniform disease entity for the purposes of translational research, and allowing the development of more formalized outcome measures aimed at treatment response.</p><p><strong>Objective: </strong>To define a set of criteria for the diagnosis of MCD.</p><p><strong>Evidence review: </strong>In this consensus statement, a panel of experts on MCD and related conditions was assembled. Their opinions were gathered regarding the clinical and histologic findings that are sufficient, necessary, and highly suggestive of MCD through serial survey. Subsequent surveys were continued until consensus was achieved. Sufficient was defined as a feature that, if noted, would enable diagnosis of MCD without any other signs, symptoms, or testing. Necessary was defined as a feature that must be present to establish a diagnosis of MCD. Highly suggestive referred to any other features that were indicative of MCD but did not qualify as sufficient or necessary to diagnose MCD.</p><p><strong>Findings: </strong>Of 24 experts invited, 19 agreed to participate, with a 79% to 100% response rate across 5 rounds conducted. Five patients were also invited to participate, but none opted to participate, citing lack of clinical expertise and time concerns. The experts were all from the US; 5 (26%) have practiced medicine for 0 to 5 years, 5 (26%) practiced for 6 to 10 years, 6 (32%) practiced for 11 to 15 years, and 3 (16%) practiced for more than 20 years. A total of 18 experts (95%) worked in an academic practice setting. There was consensus agreement that MCD could present as oral disease, genital disease, or, rarely, in another location. Consensus was achieved on 2 major and 5 minor criteria for genital/other subtypes of MCD and 5 minor criteria for oral MCD. There was consensus that, while there are some pathological findings that are highly suggestive of MCD, histologic criteria are not necessary for diagnosis.</p><p><strong>Conclusions and relevance: </strong>A panel of experts reached consensus on the diagnostic criteria for MCD described in this study. These criteria include major and minor clinical criteria, along with histopathological criteria for the diagnosis of genital and oral MCD. This consensus is a crucial step in the diagnosis of and future treatment development for MCD, a rare and clinically understudied condition.</p>\",\"PeriodicalId\":14734,\"journal\":{\"name\":\"JAMA dermatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":11.5000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1001/jamadermatol.2025.1115\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamadermatol.2025.1115","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

重要性:转移性皮肤克罗恩病(MCD)是一种罕见的疾病,目前尚无公开的诊断标准。正式的MCD诊断标准将扩大临床护理和研究,使未来的诊断代码验证成为可能,为转译研究的目的明确一个更统一的疾病实体,并允许制定针对治疗反应的更正式的结果衡量标准。目的:建立一套MCD的诊断标准。证据审查:在这份共识声明中,召集了一个MCD和相关疾病的专家小组。通过系列调查,收集了他们对充分、必要和高度提示MCD的临床和组织学发现的意见。随后的调查继续进行,直到达成协商一致意见。充分被定义为一个特征,如果注意到,可以在没有任何其他体征、症状或检测的情况下诊断MCD。必要被定义为必须存在的特征,以建立MCD的诊断。高度暗示性指的是任何其他提示MCD但不足以诊断MCD的特征。调查结果:在受邀的24位专家中,有19位同意参与,5轮调查的回复率为79%至100%。五名患者也被邀请参加,但没有人选择参加,理由是缺乏临床专业知识和时间问题。这些专家都来自美国;5人(26%)从业0 - 5年,5人(26%)从业6 - 10年,6人(32%)从业11 - 15年,3人(16%)从业20年以上。共有18位专家(95%)在学术实践环境中工作。一致同意MCD可以表现为口腔疾病、生殖器疾病,或者很少出现在其他部位。就生殖器/其他亚型MCD的2个主要标准和5个次要标准以及口腔MCD的5个次要标准达成了共识。人们一致认为,虽然有一些病理结果高度提示MCD,但诊断不需要组织学标准。结论和相关性:专家组就本研究中描述的MCD的诊断标准达成了共识。这些标准包括主要和次要的临床标准,以及诊断生殖器和口腔MCD的组织病理学标准。这一共识是MCD诊断和未来治疗发展的关键一步,MCD是一种罕见且临床研究不足的疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease: A Consensus Statement.

Importance: Metastatic cutaneous Crohn disease (MCD) is a rare condition for which there are currently no published diagnostic criteria. Formal MCD diagnostic criteria will expand clinical care and research by enabling future diagnostic code validation, crystallizing a more uniform disease entity for the purposes of translational research, and allowing the development of more formalized outcome measures aimed at treatment response.

Objective: To define a set of criteria for the diagnosis of MCD.

Evidence review: In this consensus statement, a panel of experts on MCD and related conditions was assembled. Their opinions were gathered regarding the clinical and histologic findings that are sufficient, necessary, and highly suggestive of MCD through serial survey. Subsequent surveys were continued until consensus was achieved. Sufficient was defined as a feature that, if noted, would enable diagnosis of MCD without any other signs, symptoms, or testing. Necessary was defined as a feature that must be present to establish a diagnosis of MCD. Highly suggestive referred to any other features that were indicative of MCD but did not qualify as sufficient or necessary to diagnose MCD.

Findings: Of 24 experts invited, 19 agreed to participate, with a 79% to 100% response rate across 5 rounds conducted. Five patients were also invited to participate, but none opted to participate, citing lack of clinical expertise and time concerns. The experts were all from the US; 5 (26%) have practiced medicine for 0 to 5 years, 5 (26%) practiced for 6 to 10 years, 6 (32%) practiced for 11 to 15 years, and 3 (16%) practiced for more than 20 years. A total of 18 experts (95%) worked in an academic practice setting. There was consensus agreement that MCD could present as oral disease, genital disease, or, rarely, in another location. Consensus was achieved on 2 major and 5 minor criteria for genital/other subtypes of MCD and 5 minor criteria for oral MCD. There was consensus that, while there are some pathological findings that are highly suggestive of MCD, histologic criteria are not necessary for diagnosis.

Conclusions and relevance: A panel of experts reached consensus on the diagnostic criteria for MCD described in this study. These criteria include major and minor clinical criteria, along with histopathological criteria for the diagnosis of genital and oral MCD. This consensus is a crucial step in the diagnosis of and future treatment development for MCD, a rare and clinically understudied condition.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JAMA dermatology
JAMA dermatology DERMATOLOGY-
CiteScore
14.10
自引率
5.50%
发文量
300
期刊介绍: JAMA Dermatology is an international peer-reviewed journal that has been in continuous publication since 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery. JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. It is published online weekly, every Wednesday, and in 12 print/online issues a year. The mission of the journal is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, with the aim of enabling dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. It also features research and opinion examining ethical, moral, socioeconomic, educational, and political issues relevant to dermatologists, aiming to enable ongoing improvement to the workforce, scope of practice, and the training of future dermatologists. JAMA Dermatology aims to be a leader in developing initiatives to improve diversity, equity, and inclusion within the specialty and within dermatology medical publishing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信